Pre- and postcapillary pulmonary hypertension in dogs: Circulating biomarkers

被引:4
|
作者
Oleynikov, Dmitrij Arkadievich [1 ]
Yi, Ma [2 ]
机构
[1] Vet Clin Belij Klyk, Moscow, Russia
[2] Nacl Med Issledovatelskij Ctr Imeni VA Almazova S, St Petersburg, Russia
关键词
Biomarkers; Endothelin-1; Pulmonary hypertension; Serotonin; VEGF-D; ENDOTHELIAL GROWTH-FACTOR; HEART-FAILURE; HEALTHY DOGS; VEGF-D; SEROTONIN; PLASMA; BOSENTAN; EXTENT;
D O I
10.5455/OVJ.2022.v12.i4.8
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background: Pulmonary hypertension (PH) in dogs is a syndrome that could be primary or secondary due to pulmonary disease, pulmonary thromboembolism, heartworm disease, and heart failure. Due to the inability of right heart catheterization in veterinary patients, there is a lack of differential criteria between PH forms. In some acute cases. it is impossible to provide a full EchoCG or catheterization study. In this situation, circulating markers may be useful to discover the possible mechanism of PH form and provide specific therapy. Aim: Following all previous data in human and veterinary studies, we asstunal that plasm concentration of serotonin, endothelin-1 (ET-1), and vascular endothelial growth factor D (VEGF-D) would show a predominance in affected part of pulmonary circulation. Methods: We studied 59 small-breed dogs of different sexes and ages. Groups were formed according to a primary pathology: healthy dogs (n = 8); dogs with myxomatous mitral valve disease (MMVD) and postcapillary PH (PostPH, n = 23); dogs with MMVD and precapillaty PH (PrePH, n = 28). Animals in the study were diagnosed with the primary disease by standard echocardiographic methods and algorithms. Blood samples were collected at the moment of presentation and frozen in a -80 degrees C fridge. For biochemistry analysis, we used species-specific EL1SA kits, provided by Cloud-Clone Corp. (USA). The tests were provided by the means of Almazov National Medical Research Center, IEM laboratory. Results: Dogs with EchoCG-proved PostPH had a higher concentration of VEGF-D in comparison to control and PrePH (p <0.001, for both). There was no difference between the control and PrePH groups (p >0.05). ET-1 was higher in PrePH in comparison to PostPH and control dogs (p <0.001, for both). In addition, there was no difference between the control and PostPH groups (p >0.05). Serotonin concertation did not have a difference between controls and PostPH. However, it was higher in PrePH than in control (p <0.033) and PostPH group (p <0.006). Receiver operating curve analysis showed that plasma concentrations of ET-1 (0.99) and VEGF-D (0.92) had high effectiveness in the differentiation of PostPH and PrePH. Conclusion: This study showed a correlation between circulating biomarkers (serotonin. ET-1. and VEGF-D). We found a connection between ET-1 and right-sided heart failure as well as VEGF-D and left heart failure in the PH context.
引用
收藏
页码:469 / 480
页数:12
相关论文
共 50 条
  • [31] Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study
    Evgeny Belyavskiy
    Artem Ovchinnikov
    Alexandra Potekhina
    Fail Ageev
    Frank Edelmann
    BMC Cardiovascular Disorders, 20
  • [32] Circulating Protein Biomarkers in Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Review of Published Data
    Hickey, Peter M.
    Lawrie, Allan
    Condliffe, Robin
    FRONTIERS IN MEDICINE, 2018, 5
  • [33] Circulating Collagen Biomarkers as Indicators of Disease Severity in Pulmonary Arterial Hypertension
    Safdar, Zeenat
    Tamez, Emilio
    Chan, Wenyaw
    Arya, Basant
    Ge, Yimin
    Deswal, Anita
    Bozkurt, Biykem
    Frost, Adaani
    Entman, Mark
    JACC-HEART FAILURE, 2014, 2 (04) : 412 - 421
  • [34] Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension
    Yokokawa, Tetsuro
    Boucherat, Olivier
    Martineau, Sandra
    Lemay, Sarah-Eve
    Breuils-Bonnet, Sandra
    Krishna, Vinod
    Kalyana-Sundaram, Shanker
    Jeyaseelan, Jey
    Potus, Francois
    Bonnet, Sebastien
    Provencher, Steeve
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (12):
  • [35] Four-Dimensional Magnetic Resonance Pulmonary Flow Imaging for Assessing Pulmonary Vasculopathy in Patients with Postcapillary Pulmonary Hypertension
    Nuche, Jorge
    Ponz, Ines
    Sanchez Sanchez, Violeta
    Bobeda, Javier
    Gaitan, Angel
    Lopez-Linares, Karen
    Garcia-Cosio, Maria Dolores
    Sarnago Cebada, Fernando
    Gonzalez, Javier Sanchez
    Arribas Ynsaurriaga, Fernando
    Ruiz-Cabello, Jesus
    Ibanez, Borja
    Delgado, Juan F.
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [36] Pulmonary Artery Denervation for Combined Pre- and Post-Capillary Pulmonary Hypertension Hype or Hope?
    Thenappan, Thenappan
    Gomberg-Maitland, Mardi
    JACC-HEART FAILURE, 2023, 11 (08) : 1147 - 1149
  • [37] The Quest for Metabolic Biomarkers of Pulmonary Hypertension
    Calvo, Enrique
    Garcia-Alvarez, Ana
    Vazquez, Jesus
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (02) : 190 - 192
  • [38] Associations of circulating natriuretic peptides with haemodynamics in precapillary pulmonary hypertension
    Kaiser, Ralf
    Grotemeyer, Katharina
    Lepper, Philipp
    Stokes, Caroline
    Bals, Robert
    Wilkens, Heinrike
    RESPIRATORY MEDICINE, 2015, 109 (09) : 1213 - 1223
  • [39] Effects of Exercise Training on Circulating Biomarkers of Endothelial Function in Pulmonary Arterial Hypertension
    Rodriguez-Chiaradia, Diego A. A.
    Khilzi, Karys
    Blanco, Isabel
    Rodo-Pin, Anna
    Martin-Ontiyuelo, Clara
    Herranz Blasco, Anna
    Garcia-Lucio, Jessica
    Molina, Lluis
    Marco, Ester
    Barreiro, Esther
    Piccari, Lucilla
    Peinado, Victor I. I.
    Garcia, Agustin R.
    Tura-Ceide, Olga
    Barbera, Joan Albert
    BIOMEDICINES, 2023, 11 (07)
  • [40] Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension
    Federico Luongo
    Cristiano Miotti
    Gianmarco Scoccia
    Silvia Papa
    Giovanna Manzi
    Nadia Cedrone
    Federica Toto
    Claudia Malerba
    Gennaro Papa
    Annalisa Caputo
    Giulia Manguso
    Francesca Adamo
    Dario Vizza Carmine
    Roberto Badagliacca
    Heart Failure Reviews, 2023, 28 : 745 - 755